Cargando…

Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects

BACKGROUND: Atherogenic diabetes is associated with an increased cardiovascular risk and mortality in diabetic individuals; however, the impact of insulin resistance (IR) in lipid metabolism in preclinical stages is generally underreported. For that, we evaluated the capacity of IR to predict an ath...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cartolano, Flávia De C., Dias, Gabriela D., de Freitas, Maria C. P., Figueiredo Neto, Antônio M., Damasceno, Nágila R. T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585604/ https://www.ncbi.nlm.nih.gov/pubmed/28913361 http://dx.doi.org/10.1155/2017/1018796

Ejemplares similares

Is Lipid Accumulation Product Associated with an Atherogenic Lipoprotein Profile in Brazilian Subjects?
por: Cartolano, Flavia De Conti, et al.
Publicado: (2018)

Omega-3 Fatty Acids Improve Functionality of High-Density Lipoprotein in Individuals With High Cardiovascular Risk: A Randomized, Parallel, Controlled and Double-Blind Clinical Trial
por: Cartolano, Flávia De Conti, et al.
Publicado: (2022)

Oxidized and electronegative low-density lipoprotein as potential biomarkers of cardiovascular risk in obese adolescents
por: de Freitas, Maria Camila Pruper, et al.
Publicado: (2018)

Identifying the insulin resistance index in nondiabetic Chinese subjects
por: Tuo, Xiu, et al.
Publicado: (2020)

THU335 Hyperinsulinemia Is Associated With An Atherogenic Lipoprotein Profile In Humans With Selective Insulin Resistance And An Atheroprotective Profile In Humans With Non-selective Insulin Resistance
por: Walzer, Dalia, et al.
Publicado: (2023)

Nonalcoholic steatohepatitis is associated with an atherogenic lipoprotein subfraction profile
por: Corey, Kathleen E, et al.
Publicado: (2014)

Association between Serum Albumin, Insulin Resistance, and Incident Diabetes in Nondiabetic Subjects
por: Bae, Ji Cheol, et al.
Publicado: (2013)

Green-banana biomass consumption by diabetic patients improves plasma low-density lipoprotein particle functionality
por: Lotfollahi, Zahra, et al.
Publicado: (2020)

Plasminogen Activator Inhibitor-1 Level Correlates with Lipoprotein Subfractions in Obese Nondiabetic Subjects
por: Somodi, Sándor, et al.
Publicado: (2018)

Lipoprotein Ratios as Surrogate Markers for Insulin Resistance in South Indians with Normoglycemic Nondiabetic Acute Coronary Syndrome
por: Rajappa, Medha, et al.
Publicado: (2014)

Low HDL cholesterol is associated with increased atherogenic lipoproteins and insulin resistance in women classified with metabolic syndrome
por: Fernandez, Maria Luz, et al.
Publicado: (2010)

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Reveals a More Atherogenic Profile
por: Tom, Wynnis L., et al.
Publicado: (2016)

VLDL receptor gene therapy for reducing atherogenic lipoproteins
por: Krauss, Ronald M., et al.
Publicado: (2023)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
por: Yanai, Hidekatsu, et al.
Publicado: (2022)

Statins but not fibrates improve the atherogenic to anti-atherogenic lipoprotein particle ratio: a randomized crossover study
por: Chan, Sammy Y, et al.
Publicado: (2008)

Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S.
por: Ausk, Karlee J., et al.
Publicado: (2010)

Insulin Resistance Alters Islet Morphology in Nondiabetic Humans
por: Mezza, Teresa, et al.
Publicado: (2014)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Long-term fasting improves lipoprotein-associated atherogenic risk in humans
por: Grundler, Franziska, et al.
Publicado: (2021)

The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2019)

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study
por: da Silva, Isis T, et al.
Publicado: (2013)

Patients with Rheumatoid Arthritis Show Altered Lipoprotein Profiles with Dysfunctional High-Density Lipoproteins that Can Exacerbate Inflammatory and Atherogenic Process
por: Kim, Jae-Yong, et al.
Publicado: (2016)

Helicobacter pylori Infection and Insulin Resistance in Diabetic and Nondiabetic Population
por: Vafaeimanesh, Jamshid, et al.
Publicado: (2014)

Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2013)

Atherogenic Lipoprotein(a) Increases Vascular Glycolysis, Thereby Facilitating Inflammation and Leukocyte Extravasation
por: Schnitzler, Johan G., et al.
Publicado: (2020)

Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome
por: Irawati, Deasy, et al.
Publicado: (2016)

High Density Lipoprotein Particle Size in Children: Relation to Atherogenic Dyslipidemia
por: Numata, Michio
Publicado: (2004)

The Ratio of Unesterified/esterified Cholesterol is the Major Determinant of Atherogenicity of Lipoprotein Fractions
por: Bagheri, Babak, et al.
Publicado: (2018)

Investigating the Atherogenic Risk of Lipoprotein(a) in Type 2 Diabetic Patients
por: Peela, Jagannadha R, et al.
Publicado: (2018)

The Effect of Untraditional Lipid Parameters in the Development of Coronary Artery Disease: Atherogenic Index of Plasma, Atherogenic Coefficient and Lipoprotein Combined Index
por: Çelik, Ersin, et al.
Publicado: (2021)

High-Density Lipoprotein Cholesterol in Young Nondiabetic Coronary Heart Disease Patients
por: Hu, Ziyang, et al.
Publicado: (2021)

Blood Mercury and Insulin Resistance in Nondiabetic Koreans (KNHANES 2008-2010)
por: Kim, Kyu-Nam, et al.
Publicado: (2015)

Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
por: Lotfollahi, Zahra, et al.
Publicado: (2022)

Author Correction: The LipoGlo reporter system for sensitive and specific monitoring of atherogenic lipoproteins
por: Thierer, James H., et al.
Publicado: (2020)

Insulin Topical Application for Wound Healing in Nondiabetic Patients
por: Sun, Shudong, et al.
Publicado: (2021)

Erratum to: Cholesterol Forms and Traditional Lipid Profile for Projection of Atherogenic Dyslipidemia: Lipoprotein Subfractions and Erythrocyte Membrane Cholesterol
por: Uydu, Hüseyin Avni, et al.
Publicado: (2014)

Higher hemoglobin A1C and atherogenic lipoprotein profiles in children and adolescents with type 2 diabetes mellitus
por: Pelham, James Heath, et al.
Publicado: (2018)

Impact of menopause and diabetes on atherogenic lipid profile: is it worth to analyse lipoprotein subfractions to assess cardiovascular risk in women?
por: Fonseca, Marília Izar Helfenstein, et al.
Publicado: (2017)

Increased Circulating Levels of PCSK9 and Pro-Atherogenic Lipoprotein Profile in Pregnant Women with Maternal Supraphysiological Hypercholesterolemia
por: Cantin, Claudette, et al.
Publicado: (2022)

Ezetimibe ameliorates atherogenic lipids profiles, insulin resistance and hepatocyte growth factor in obese patients with hypercholesterolemia
por: Adachi, Hisashi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_pa72lcf4t1r7qrsnp7hvcamoe4